GPT and inflammatory bowel disease: Elevated ALT is a well-recognized biomarker of liver cell injury and its rise in our model mirrors the liver dysfunction commonly observed in patients with inflammatory bowel disease (IBD), reinforcing the clinical relevance of our findings (Hanafy et al., 2016; Mendes et al., 2007).